US Stock MarketDetailed Quotes

ESLAW ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM)

Watchlist
  • 0.036
  • 0.0000.00%
Close Jul 10 16:00 ET
0Market Cap0.00P/E (TTM)

ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
(Q3)Mar 29, 2022
(FY)Jun 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-4,914.13%-4.23M
-10,313.48%-11.27M
74.99%-275.19K
21.30%-84.45K
-108.2K
-1.1M
-114.96%-1.44M
-926.67K
-107.31K
-670.82K
Net income from continuing operations
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-1,528.78%-2.74M
---2.76M
---2.89M
-129.71%-1.69M
---1.07M
---168.29K
---733.69K
Depreciation and amortization
--0
----
----
--5.49K
----
----
----
----
----
----
Change In working capital
-247.72%-3.77M
-503.91%-10.25M
-76.19%400.65K
--2.55M
--2.54M
--1.68M
--113.35K
--113.35K
--0
--0
-Change in prepaid assets
-6,909.72%-3.5M
---262.48K
--0
---50K
--0
--833.33K
---833.33K
---833.33K
--0
--0
-Change in payables and accrued expense
-110.02%-260.24K
-493.66%-9.98M
-52.81%400.65K
--2.6M
--2.54M
--849.06K
--946.68K
--946.68K
--0
--0
-Change in other current liabilities
--0
--0
--0
--512
--585
--430
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-4,914.13%-4.23M
-10,313.48%-11.27M
74.99%-275.19K
21.30%-84.45K
---108.2K
---1.1M
-114.96%-1.44M
---926.67K
---107.31K
---670.82K
Investing cash flow
Cash flow from continuing investing activities
0
5.07M
-112.3K
-136.53K
0
0
Net other investing changes
--0
--5.07M
---112.3K
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--5.07M
---112.3K
---136.53K
--0
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-84.09K
-6.9M
20.05M
0
0
0
724.42%5.53M
5.02M
107.31K
670.82K
Net issuance payments of debt
--0
---5.37M
--300K
--0
--0
--0
----
----
----
----
Net common stock issuance
---84.09K
--0
--10M
--0
--0
--0
----
----
----
----
Net preferred stock issuance
--0
--0
--9.02M
--0
--0
--0
--5M
--5M
----
--0
Proceeds from stock option exercised by employees
----
----
----
----
----
----
--15K
--15K
----
--0
Net other financing activities
--0
---1.53M
--726.34K
----
----
----
----
----
--107.31K
--670.82K
Cash from discontinued financing activities
Financing cash flow
---84.09K
---6.9M
--20.05M
--0
--0
--0
724.42%5.53M
--5.02M
--107.31K
--670.82K
Net cash flow
Beginning cash position
214.11%9.05M
640.87%22.14M
-39.36%2.48M
--2.88M
--2.99M
--4.09M
--0
--0
--0
--0
Current changes in cash
-1,854.29%-4.32M
-12,000.24%-13.09M
1,886.80%19.66M
---220.99K
---108.2K
---1.1M
----
--4.09M
----
----
End cash Position
77.79%4.73M
214.11%9.05M
640.87%22.14M
--2.66M
--2.88M
--2.99M
--4.09M
--4.09M
--0
--0
Free cash flow
-4,914.13%-4.23M
-10,313.48%-11.27M
74.99%-275.19K
21.30%-84.45K
---108.2K
---1.1M
-114.96%-1.44M
---926.67K
---107.31K
---670.82K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022(FY)Jun 30, 2022(Q4)Jun 30, 2022(Q3)Mar 29, 2022(FY)Jun 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -4,914.13%-4.23M-10,313.48%-11.27M74.99%-275.19K21.30%-84.45K-108.2K-1.1M-114.96%-1.44M-926.67K-107.31K-670.82K
Net income from continuing operations 82.87%-469.53K62.97%-1.02M35.17%-1.87M-1,528.78%-2.74M---2.76M---2.89M-129.71%-1.69M---1.07M---168.29K---733.69K
Depreciation and amortization --0----------5.49K------------------------
Change In working capital -247.72%-3.77M-503.91%-10.25M-76.19%400.65K--2.55M--2.54M--1.68M--113.35K--113.35K--0--0
-Change in prepaid assets -6,909.72%-3.5M---262.48K--0---50K--0--833.33K---833.33K---833.33K--0--0
-Change in payables and accrued expense -110.02%-260.24K-493.66%-9.98M-52.81%400.65K--2.6M--2.54M--849.06K--946.68K--946.68K--0--0
-Change in other current liabilities --0--0--0--512--585--430----------------
Cash from discontinued investing activities
Operating cash flow -4,914.13%-4.23M-10,313.48%-11.27M74.99%-275.19K21.30%-84.45K---108.2K---1.1M-114.96%-1.44M---926.67K---107.31K---670.82K
Investing cash flow
Cash flow from continuing investing activities 05.07M-112.3K-136.53K00
Net other investing changes --0--5.07M---112.3K----------------------------
Cash from discontinued investing activities
Investing cash flow --0--5.07M---112.3K---136.53K--0--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities -84.09K-6.9M20.05M000724.42%5.53M5.02M107.31K670.82K
Net issuance payments of debt --0---5.37M--300K--0--0--0----------------
Net common stock issuance ---84.09K--0--10M--0--0--0----------------
Net preferred stock issuance --0--0--9.02M--0--0--0--5M--5M------0
Proceeds from stock option exercised by employees --------------------------15K--15K------0
Net other financing activities --0---1.53M--726.34K----------------------107.31K--670.82K
Cash from discontinued financing activities
Financing cash flow ---84.09K---6.9M--20.05M--0--0--0724.42%5.53M--5.02M--107.31K--670.82K
Net cash flow
Beginning cash position 214.11%9.05M640.87%22.14M-39.36%2.48M--2.88M--2.99M--4.09M--0--0--0--0
Current changes in cash -1,854.29%-4.32M-12,000.24%-13.09M1,886.80%19.66M---220.99K---108.2K---1.1M------4.09M--------
End cash Position 77.79%4.73M214.11%9.05M640.87%22.14M--2.66M--2.88M--2.99M--4.09M--4.09M--0--0
Free cash flow -4,914.13%-4.23M-10,313.48%-11.27M74.99%-275.19K21.30%-84.45K---108.2K---1.1M-114.96%-1.44M---926.67K---107.31K---670.82K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg